Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-26-000191·KalVista Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
KalVista Pharmaceuticals Inc
Common Stock, par value $0.001 per share · CUSIP: 483497103
Event date: 2026-01-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 2,781,902.00 · Class: 5.5%
- Point72 Capital Advisors, Inc.
Shares: 2,781,902.00 · Class: 5.5%
- Steven A. Cohen
Shares: 2,781,902.00 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-26-000191
- Form type
- SCHEDULE 13G/A
- Filer
- KalVista Pharmaceuticals, Inc.
- CIK
- CIK 1348911
- Filed
- Jan 13, 2026
- Reporting period
- Jan 05, 2026
- Description
- Schedule 13G beneficial ownership